ENTO vs BAOS

Comparison between Entero Therapeutics, Inc. Common Stock (ENTO, Company) and Baosheng Media Group Holdings Ltd (BAOS, Company).

ENTO is from the Healthcare sector, while BAOS is from the Communication Services sector.

5-Year PerformanceBAOS has outperformed ENTO, delivering a return of -46.7% compared to -86.1%

ENTO vs BAOS - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	ENTO(COMPANY)	BAOS(COMPANY)
Market Cap	$4.26M	$4.25M
Max Drawdown	100.00%	99.09%
Sharpe Ratio	1.55	0.40
5Y Beta	N/A	1.54
Industry	Biotechnology	Advertising Agencies
P/E Ratio	-2.89	-0.35
Debt to Equity	2.51%	0.00%
Free Cash Flow Yield	-44.58%	-53.26%
P/B Ratio	0.15	N/A

Market Cap

Winner

ENTO

$4.26M

BAOS

$4.25M

Max Drawdown

ENTO

100.00%

Winner

BAOS

99.09%

Sharpe Ratio

Winner

ENTO

1.55

BAOS

0.40

5Y Beta

ENTO

N/A

BAOS

1.54

Industry

ENTO

Biotechnology

BAOS

Advertising Agencies

P/E Ratio

Winner

ENTO

-2.89

BAOS

-0.35

Debt to Equity

ENTO

2.51%

Winner

BAOS

0.00%

Free Cash Flow Yield

Winner

ENTO

-44.58%

BAOS

-53.26%

P/B Ratio

ENTO

0.15

BAOS

N/A

ENTO vs BAOS - Historical Returns

Returns include dividend reinvestment.

Period	ENTO	BAOS
1 month	+42.86%	-3.82%
3 months	+152.34%	+4.14%
6 months	+169.33%	-6.10%
1 year	+271.67%	-1.77%
5 years(CAGR)	-86.13%	-46.72%
10 years(CAGR)	-70.01%	N/A
Max(CAGR)	-70.01%	-53.65%

Winner

ENTO

+42.86%

BAOS

-3.82%

Winner

ENTO

+152.34%

BAOS

+4.14%

Winner

ENTO

+169.33%

BAOS

-6.10%

Winner

ENTO

+271.67%

BAOS

-1.77%

5Y(CAGR)

ENTO

-86.13%

Winner

BAOS

-46.72%

10Y(CAGR)

ENTO

-70.01%

BAOS

N/A

Max(CAGR)

ENTO

-70.01%

Winner

BAOS

-53.65%

ENTO vs BAOS - Annual Returns (2016 - 2026)

Returns include dividend reinvestment.

Year	ENTO	BAOS
2026	+5.06%	+4.92%
2025	+139.71%	+1.49%
2024	-83.72%	-23.12%
2023	-96.61%	-31.63%
2022	-98.24%	-70.79%
2021	-83.94%	-89.90%
2020	-5.83%	N/A
2019	-20.00%	N/A
2018	-67.39%	N/A
2017	-14.42%	N/A
2016	-4.82%	N/A